% INTRODUCTION CONTENT

\section{The cell}
The cell is the smallest unit of life, of which all known living organisms are composed. Every cell houses a plethora of biomolecular processes that allows it to continuously adapt to changes in its environment. Due to the dynamic nature of these processes, it can be very challenging to comprehend the cellular response to a signal. A reductionist approach to understanding a complex biological system is to study the biochemical components of which it is comprised \cite{brigandt_reductionismbiology_2017}.

Recent advances in experimental technologies are playing a crucial role in reductionist biology, allowing to measure the abundance of thousands of different biochemical molecules in tens of thousands of individual cells. With it comes the challenge of analysing large amounts of data that are not easily interpretable by hand. The sheer volume of the data generated from such highly-integrative and high-throughput experiments are not the only reason why they are so challenging to interpret. For instance, the generated data contains high levels of noise arising from inherent biomolecular stochasticity in the cells and from the experimental profiling techniques used, as well as batch effects arising from differences between donors and labs \cite{hon_humancellatlas_2018}. Biologists thus turn to computer scientists
to develop new tools to tackle these problems and help them to extract meaningful biological insights from the data. In this work, incremental contributions were made to the field in order to be able to address the aforementioned problems in a more comprehensive context.

Observing the biomolecular insides of cells can ultimately provide fundamental understanding into the processes that govern these cells and help uncover novel approaches for disease diagnosis, prognosis, and treatment. For example, the Human Cell Atlas (HCA) consortium \cite{regev_humancellatlas_2018} has set out to develop a comprehensive reference map of all the different types of cells in the human body. Experts in the field often metaphorically describe the HCA initiative as aiming to develop a 'Google Maps' of the human body. Even in its infancy, the HCA has profiled 3.8 million cells from 248 donors across 42 labs \cite{humancellatlasconsortium_humancellatlas_2018}, and this number is likely to increase well above one hundred million.

The next part of the chapter highlights several key concepts in both cell biology and computer science, upon which the remainder of this work relies.

\subsection{The origin of life and the RNA world}
The discovery of the double helix shape of deoxyribonucleic acid (DNA) \cite{watson_molecularstructurenucleic_1953} is often considered the pivot point in our understanding of the origin of life and evolution. By now, it is well known that DNA serves as a medium for storing the genetic information required to reproduce a whole organism. With other words, the DNA of an organism contains the complete set of instructions required to build all of the biomolecular machinery present in its body. 

Life (or cells) did not originate from DNA, however. A widely-accepted hypothesis states that life originates from its lesser-known cousin, ribonucleic acid (RNA). According to the RNA world hypothesis \cite{alberts_rnaworldorigins_2002}, the very first primitive cells used RNA both to store genetic information and to perform the chemical reactions required to sustain themselves (Figure \ref{fig:rnaworld}). Only later did cells develop the ability to use the more chemically stable DNA molecules to self-sustain in a process commonly referred to as the central dogma.

\begin{figure}[htb!]
	\centering
	\includegraphics[width=.8\linewidth]{fig/rnaworld}
	\caption{
		\textbf{RNA world.} The postulated rise and fall of the RNA world during the evolution of life, from early self-replicating RNA to complex, RNA-controlled metabolism, to the invention of translation, followed by diversification of all modern branches of life. Adapted from Horning (2011) \cite{horning_rnaworld_2011}.
	}
	\label{fig:rnaworld}
\end{figure}

\subsection{Central dogma}
The central dogma describes the general flow of genetic information in almost all existing living cells: DNA is decoded to RNA, which in turn encodes proteins \cite{strachan_humanmoleculargenetics_2011}. Main processes involved in the central dogma are \textbf{transcription}, \textbf{splicing}, and \textbf{translation} (Figure \ref{fig:centraldogma}). 

\begin{figure}[htb!]
	\centering
	\includegraphics[width=.8\linewidth]{fig/central_dogma.pdf}
	\caption{	
		\textbf{The central dogma of molecular biology explains the flow of genetic information, from DNA to RNA, to protein.}
	}
	\label{fig:centraldogma}
\end{figure}

During the process of \textbf{transcription} that takes place in the cell nucleus, a complementary RNA copy is transcribed from the template DNA. The initial RNA transcript is a precursor messenger RNA (pre-mRNA) that needs to undergo series of maturation steps to ultimately form the mature messenger RNA (mRNA). This maturation includes pre-mRNA \textbf{splicing} to remove non-protein coding intervening sequences (the introns) and to join the neighbouring protein-coding sequences (the exons). A single pre-mRNA can be alternatively spliced to generate multiple forms of mRNAs that will result in the production of multiple protein isoforms. This process of alternative splicing is essential to generate more than 100'000 different proteins starting from just 20'000 genes \cite{nilsen_expansioneukaryoticproteome_2010}.

The mature mRNA is then transported to the cytoplasm, where it engages with ribosomes to initiate \textbf{translation}. During this highly evolutionary conserved process, a chain of amino acids, known as the protein building blocks, is being synthesised. Each amino acid is specified by three nucleotides (a codon) in the mRNA, according to a nearly universal genetic code. After being released by the ribosomes, the translation product undergoes a variety of chemical modifications to form the final folded protein, the structure of which is determined by the sequence of different amino acids in the chain. In addition, polypeptides may be cleaved to yield more than one active polypeptide product. The structure of a protein determines its functionality, which includes catalysing biochemical reactions, providing structure, and transportation of molecules.


\subsection{Cell types}
Ever since Robert Hook first described the different structures of cells in 1665, biologists have been classifying cells by form and function.
The human body is said to contain more than 210 different cell types that are classified into four groups: epithelial, connective, muscle, and nervous. This however, is a major underestimation of the real number of cell types. Neurons, for instance, that are known to be extremely diverse, are estimated to reach numbers above 10,000 different types \cite{strachan_humanmoleculargenetics_2011}.

The concept of cell types eases reasoning and our understanding about many aspects of biology (e.g. the process of cell differentiation, cell-cell communication, cellular response to certain stimuli). Some cells are known to be highly specialised toward performing a particular function (e.g. memory B cells accelerate immune response by remembering previously encountered pathogens), or they can maintain a strong ability to differentiate into other cell types.

One common approach for understanding the functionality of a particular cell is to observe which molecules are present in the cell and to associate those set of molecules with functionality. Taking a snap shot of the protein or RNA transcript content in a particular cell, might already provide us with major insights into its functionality. However, in order to fulfil a particular task, the biochemical machinery of the cell gradually changes over time. Therefore it is highly informative to also consider the transition states between cell types and the dynamic processes involved therein.

\subsection{Cell dynamics and gene regulation}
Cells are dynamic entities that can gradually produce the molecules needed to acquire new functionality. The naturally occurring cell-to-cell variability happens at the level of gene expression. Gene expression itself can be controlled at different levels (Figure~\ref{fig:controlexpression}), one of which is gene regulation by transcription.

\begin{figure}[ht!]
	\centering
	\includegraphics[width=\linewidth]{fig/control_gene_expression}
	\caption{
		\textbf{Levels of controlling gene expression} can happen at the level of transcription, RNA processing (i.e. splicing), RNA transport and localization, mRNA translation, mRNA degradation and protein activity \cite{alberts_overviewgenecontrol_2002}.
	}
	\label{fig:controlexpression}
\end{figure}

According to the needs of a cell, different genes are being transcribed. Housekeeping genes are being expressed in essentially every cell, while other genes are cell type or tissue specific or may be expressed in response to developmental and environmental signals \cite{strachan_humanmoleculargenetics_2011}. 

Transcription factors (TFs) modulate the rate of gene transcription by binding and recruiting the transcriptional machinery to \emph{cis}-regulatory regions (enhancers, and silencers) that are typically located in the promotor region of target genes. These bindings may result in increased or decreased gene expression. 
There are several TF families of which members share structural characteristics (e.g. zinc finger, helix-loop-helix).

Many TFs are commonly present in virtually all cell types (e.g. NF-$\kappa$B), while others are specific for cells and developmental stages \cite{lambert_humantranscriptionfactors_2018}. Typically, the same TF can regulate the rate of transcription of many target genes in different cell types, indicating that these gene regulatory networks (GRNs) are dynamic. Moreover, the production of a specific molecule might require several gene regulatory cascades. Studying the active parts of a cell's GRN can thus reveal which dynamic processes are taking place within a cell.

% KDP: misschien interessant om over tumor heterogeniteit te spreken: waarvan we vroeger dachten dat homogene massa van cellen was, blijkt toch veel complexer te zijn --> nu mogelijk om met sc technieken te bestuderen?

\subsection{Profiling single cells}
Several technologies are now available to profile (i.e. observe) biomolecular components, allowing us to gain better understanding in the biological processes that take place within a cell. The single-cell "omics" technologies originated from the convergence of two different fields, \emph{"single-cell"} and \emph{"omics"}.

\subsubsection{Single-cell}
The earliest approach for measuring the abundance of a particular molecule in \emph{single cells} is the microscope.
Since its development by Coons et al. (1941), immunohistochemistry (IHC) has been instrumental in visualising proteins \cite{coons_immunologicalpropertiesantibody_1941}. 
A cell can present a particular type of protein, also called an antigen, on its cell surface. In many multicellular organisms, antigens can stimulate the immune system to produce antibodies. IHC realises the visualisation of proteins by exploiting the principle of antibodies binding to specific antigens.

IHC (and many other biotechnologies) visualises antigen-antibody reactions by attaching particular molecules to the antibody, such as an enzyme that catalyses a colour-producing reaction, or a fluorescent chemical compound that can re-emit light upon excitation. The use of several colours (wavelengths) allows measuring expression levels of different antibodies simultaneously. Characterising cells in a semi-quantifiable way is labour intensive, however; since it involves acquiring an image of many cells and drawing a contour around each cell (called cell segmentation).
Modern implementations of IHC improve the throughput drastically by using robots and computer software to provide semi-automated image acquisition and cell segmentation \cite{theodosiou_automatedanalysisfish_2007}.

Flow cytometry \cite{fulwyler_electronicseparationbiological_1965} circumvents imaging and segmentation issues by measuring fluorescently labelled proteins as cells pass through a fluidic system.
Since cells need to be suspended in a buffer, flow cytometry is particularly useful for analysing non-adherent cells such as the many different immune cells in blood. However, many protocols already exist to extract viable single cells from tissues and tumours \cite{leelatian_preparingviablesingle_2017}.
Conventional flow cytometry devices enable to measure protein expression levels of millions of cells using up to eight different antibody fluorochromes simultaneously, while state-of-the-art instrumentation allows detection of up to 27 biomarkers simultaneously \cite{cossarizza_guidelinesuseflow_2017}.

Besides IHC and flow cytometry, many new technologies have been developed which allow quantifying expression levels of molecules in single cells (e.g. mass cytometry, single-cell quantitative polymerase chain reaction, fluorescence \emph{in situ} hybridization). All of these single-cell (non-omics) technologies are limited by the number of different molecules they measure, however. Selecting molecules of interest prior to analysis, makes the experiment biased towards the preconceptions of the experimenter.

\subsubsection{Omics}
On the other side of the spectrum are the so-called "omics" technologies. "Omics"\footnote{The etymology of "omics" is quite interesting \cite{yadav_wholenesssuffixomics_2007}.} is a collective term for profiling all molecules of a particular type in a high-throughput manner.
There are at least ten types of "omics". In this work, we mostly consider genomics, transcriptomics, proteomics, and regulomics. Genomics studies the complete DNA sequence of an organism's genome, while transcriptomics and proteomics study the RNA transcripts and proteins, respectively. Regulomics studies the regulatory molecules (e.g. genes, RNAs, proteins) which play a role in determining gene regulation.

Specific examples of omics technologies are whole genome sequencing to determine the DNA sequence of an organism, and RNA sequencing to profile the sequence of RNA transcripts, both using next-generation sequencing technologies. A gene expression profile can be obtained by mapping the sequences of RNA transcripts to the genome.

Several high-throughput technologies have been developed to investigate proteomes in depth. The most commonly applied are mass spectrometry-based and gel-based techniques (e.g. differential in-gel electrophoresis).

% Je had proteomics technieken niet meer aangehaald. -> zie deze paperlink voor eventueel fig 1 of 2. Hoewel dit misschien niet je hoofdtopic is. https://academic.oup.com/chromsci/article/55/2/182/2333796

Typically for these methods, to capture enough material to generate a profile, numerous cells need to be pooled and lysed together, thereby granting the technology's name "bulk" omics.
Bulk omics is a major workhorse in molecular genetics and has applications in cancer research and in diagnostic screening of inheritable disorders.

Increasing evidence shows that cells are biomoleculary heterogeneous, even in very similar cell types \cite{hwang_singlecellrnasequencing_2018} (Figure~\ref{fig:bulk_vs_sc}A). Since a bulk profile is a population average (or rather, a summation), important cell-to-cell variability is not discernible (Figure~\ref{fig:bulk_vs_sc}B). 

\begin{figure}[htb!]
	\centering
	\includegraphics[width=0.6\textwidth]{fig/bulk_vs_sc} 
	\caption{
		\textbf{The 'masking' effect of bulk omics.} 
		\textbf{A:} Cells from several subpopulations are incorrectly assumed to be homogeneous and are profiled with a single bulk omics experiment.
		\textbf{B:} The signals from the different subpopulations are masked. The resulting profile is dissimilar from the majority of cells it is supposed to represent.
	}
	\label{fig:bulk_vs_sc}
\end{figure}

\subsubsection{Single-cell omics}
Comparing single-cell technologies with omics technologies shows that they have both clear advantages but also significant drawbacks (Figure \ref{fig:profiling_convergence}A). Single-cell biology allows profiling thousands or even millions of cells, but only for a select number of genes. On the other hand, omics biology provides a broader view -- since genes do not need to be selected beforehand -- but is a profile of ensemble of cells and thus masks important cellular heterogeneity.

Advances in microvolume sequencing allowed profiling the transcriptome at single-cell resolution, thereby bringing single-cell biology and omics together to create single-cell omics. During the decade that followed, the number of single-cell omics technologies has sky-rocketed, allowing to profile >100'000 cells \cite{svensson_exponentialscalingsinglecell_2018} and measuring other levels of information (e.g. protein abundance and spatial location) \cite{moudgil_multimodalscrnaseq_2019}.

\begin{figure}[htb!]
	\centering
	\includegraphics[width=.7\linewidth]{fig/scomics_2.pdf} 
	\caption{
		\textbf{A:} Technological improvements in microfluidics and low-volume sequencing were instrumental in the convergence of the fields of single-cell biology and omics biology.
		\textbf{B:} Different approaches for sampling cells with decreasing levels of cellular heterogeneity within the different sub-populations: snapshot, time-series, sorted.
		\textbf{C:} Two common single-cell RNA sequencing technologies. Microfluidics systems let cells travel through nanometer scale tubing, capturing individual cells at intersections. Droplet-based systems encapsulate individual cells in droplets.
	}
	\label{fig:profiling_convergence}
\end{figure}

% could be expanded with information on how to isolate single cells and how to profile them
% see https://www.nature.com/articles/s12276-018-0071-8
% seems interesting as well: 10.1146/annurev-biodatasci-080917-013452

In this work, unless noted otherwise, we will be working with transcriptomics data resulting from a single-cell RNA-sequencing experiment (scRNA-seq). The workflow of generating scRNA-seq profiles is as follows. Same as other single-cell (non-omics) profiling methods, cells first need to be isolated (Figure~\ref{fig:profiling_convergence}B). Different sampling techniques yield different levels of information about cellular state. By now, many protocols for extracting and tagging RNA from single cells have been developed \cite{svensson_exponentialscalingsinglecell_2018}, the most popular of which are based on microfluidics or droplets (Figure~\ref{fig:profiling_convergence}C). By sequencing the transcripts and the attached unique cell identifier tags, each read can be mapped and tallied up. scRNA-seq data can thus be summarised in a matrix, where each column represents a single cell, each row a gene, and each value represents the number of transcripts that were sequenced for that gene and cell.

The rapidly advancing field of single-cell omics harbours exceptional opportunities to discover new aspects of biology and redefine existing knowledge. Some of these opportunities lie in efforts like the HCA consortium \cite{regev_humancellatlas_2018}. They have set out to redefine all human cell types in both terms of their gene expression and location, and as well as the developmental trajectories connecting the different cell types. As part of this endeavour, the consortium will likely profile the whole transcriptomes of tens or even hundreds of millions of cells \cite{humancellatlasconsortium_humancellatlas_2018}. 

\section{Computational tools} \label{sec:comptools}
Whole-genome profiling at single-cell level allows new types of analyses with which to study cellular heterogeneity at a hitherto unseen throughput. 
The new types of analyses permitted by single-cell omics present several computational challenges \cite{stegle_computationalanalyticalchallenges_2015, yuan_challengesemergingdirections_2017, chen_singlecellrnaseqtechnologies_2019}. This necessitates the development of novel computational tools, either because the problem statement of the performed analysis is completely novel, or to adapt existing methodology to new data characteristics -- dimensionality and noise. 

scRNA-seq data is typically very sparse -- while the human genome has more than 20'000 genes, they only contain non-zero values of a few thousand genes (typically less than 4'000). This is partially due to cells being specialised in particular functions and thus they do not need proteins of every time, but also due to RNA transcription occurring in bursts rather than continuously \cite{nicolas_whatshapeseukaryotic_2017}. This contributes to the high levels of noise seen in scRNA-seq data: no two cells have the same set of non-zero genes. 

Over the past five years, already 450 new tools have been developed to perform various analyses of single-cell omics data \cite{zappia_exploringsinglecellrnaseq_2018}. Most of these tools belong to one (or more) of the five main classes of computational methods used within single-cell omics (Figure~\ref{fig:scapplications}). The main concepts and applications of these types of analyses are discussed in the following sections.


\begin{figure}[htb!]
	\centering
	\includegraphics[width=\linewidth]{fig/singlecell_technologies_onlycore} 
	\caption{
		\textbf{Five main types of analyses typically performed with single-cell omics, and the applications thereof.}
	}
	\label{fig:scapplications}
\end{figure}


\subsection{Dimensionality reduction}
Single-cell omics datasets are usually one or more high-dimensional matrices, containing between M = $10^3$ to $10^5$ cells and typically about N = $10^3$ to $10^4$ genes (Figure~\ref{fig:comp_tools_dimred}A). The dimensionality of such datasets is typically too high for humans to interpret manually and for most modelling algorithms to tackle directly. 
Moreover, in reality, the intrinsic dimensionality of biological systems is much lower. For example, a differentiating hematopoietic cell could be described by just three dimensions: the first two dimensions lays out the hematopoietic lineage tree, and a third dimension allows for reprogramming between branches to occur.

Dimensionality reduction (DR) methods transform high-dimensional data into a meaningful low-dimensional representation. DR methods are typically one of the first methods to apply on the data as a visual quality control by asserting that cells group together in ways that are expected.

DR methods have two main target audiences; computers -- to construct a K-dimensional (with K $\ll$ N) representation of the data such that pairwise distances between different samples are retained as well as possible (Figure~\ref{fig:comp_tools_dimred}B); and humans -- to obtain a visual overview of the data (Figure~\ref{fig:comp_tools_dimred}C). DR methods are also commonly used to denoise the data, which is particularly useful since single-cell omics data is inherently noisy.

Each dimension frequently corresponds to one or more modules of co-expressed genes. The reduced space can be interpreted in way analogous to Waddingtonâ€™s epigenetic landscapes \cite{waddington_strategygenesdiscussion_1957,ferrell_bistabilitybifurcationswaddington_2012,rebhahn_animatedlandscaperepresentation_2014}, where the landscape dictates the possible states a cell can reside in, and transitions between states correspond to dynamic cellular processes, such as cell differentiation. 

\begin{figure}[htb!]
	\centering
	\includegraphics[width=\linewidth]{fig/comptools2/comptool_1_dimred.pdf} 
	\caption{
		\textbf{Dimensionality reduction for single-cell omics data.}
		\textbf{A:} A heatmap visualisation of an scRNA-seq expression dataset of fibroblasts being reprogrammed to neuron cells \cite{treutlein_dissectingdirectreprogramming_2016}. Only the most variable 
		\textbf{B:} The reduced space is a M$\times$K-dimensional matrix which attempts to conserve the cellular heterogeneity of the original space as well as possible.
		\textbf{C:} A dot plot of the first two components of the reduced space provides a global overview of the cells in the dataset. Colouring the dots according to prior information (e.g. cell type) or gene expression provides insight into the cellular heterogeneity within the dataset.
	}
	\label{fig:comp_tools_dimred}
\end{figure}

DR methods can be classified into two main categories, feature projection-based and manifold learning \cite{engel_surveydimensionreduction_2012}. 

Projection-based DR methods aim to perform a transformation of the data while preserving the pairwise distances between samples as much as possible. Examples of commonly used projection-based DR methods in single-cell omics are Principal Component Analysis \cite{pearson_liiilinesplanes_1901} (PCA) and Multi-Dimensional Scaling \cite{kruskal_multidimensionalscalingoptimizing_1964} (MDS). 

Manifold learning DR methods reconstruct a higher-order structure in the original space (e.g. a graph or a grid), visualising the structure in a lower-dimensional space, and mapping the original samples to the lower-dimensional space. Manifold learning can be an iterative optimisation process using a predefined criterion. Examples of manifold learning techniques are t-distributed Stochastic Neighbor Embedding \cite{vandermaaten_visualizingdatausing_2008} (t-SNE), Diffusion Maps \cite{nadler_diffusion_2005,coifman_diffusionmaps_2006} and Uniform Manifold Approximation and Projection \cite{mcinnes_umapuniformmanifold_2018} (UMAP). 

For scalability reasons, this work mostly makes use of Landmark MDS \cite{silva_globallocalmethods_2002,lee_landmarkmdsensemble_2009} (LMDS) with a Spearman rank correlation distance metric. LMDS is an extension of classical MDS, but rather than calculating a complete distance matrix between all pairs of cells, a set of landmark cells is sampled, only the distances between a set of landmarks and the samples are calculated. 

\subsection{Clustering}
Clustering methods divide up the cells into separate groups of highly similar cells in order to delineate cell populations (Figure~\ref{fig:comp_tools_cluster}A). By visualising gene expression of known genes involved in the cell types of interest, the clusters can be annotated (Figure~\ref{fig:comp_tools_cluster}B). Particular clustering methods might be developed to better deal with imbalanced data in order to better identify rare cell type populations.

\begin{figure}[htb!]
	\centering
	\includegraphics[width=.6\linewidth]{fig/comptools2/comptool_2_clustering.pdf} 
	\caption{
		\textbf{Clustering for single-cell omics data.}
		\textbf{A:} Clustering methods group cells with similar omics profiles together. 
		\textbf{B:} By overlaying gene expression levels on a dimensionality reduction, the clusters can be annotated to allow better interpretation of the cellular heterogeneity.
	}
	\label{fig:comp_tools_cluster}
\end{figure}


Usually, the number of clusters is determined by the user, either as a direct parameter (e.g. $k$-means \cite{lloyd_leastsquaresquantization_1982}) or an indirect parameter (e.g. a height cutoff in hierarchical clustering). In some exceptional cases, the number of clusters is strictly determined by the data itself and cannot be altered with a parameter (e.g. Louvain clustering \cite{blondel_fastunfoldingcommunities_2008}).

Clustering methods used in this work are mostly restricted to $k$-Means for clustering low-dimensional spaces and Louvain for clustering networks, since both are highly scalable with respect to the number of cells.

\subsection{Trajectory inference}
While clustering methods divide cells into distinct groups, trajectory inference (TI) methods acknowledge that cells are dynamic entities which transition from once cellular state to another via various dynamic processes. Rather than making distinct groups, TI methods attempt to predict how cells develop or undergo dynamic processes. The main applications of trajectory inference are to identify cellular states and branchpoints, reconstruct the topology of dynamic processes, and identify state-specific markers. 

TI methods try to reconstruct the topology of a dynamic process as a trajectory and subsequently map the cells onto that trajectory. A trajectory is a graph where the nodes represent noteworthy cellular states, and each cell is predicted to be progressing along transitions between the different states (Figure~\ref{fig:comp_tools_ti}A).

A trajectory can be visualised as a graph to better highlight the topology of the trajectory(Figure~\ref{fig:comp_tools_ti}A middle), as a heatmap to better depict the changes in gene expression along the different transitions (Figure~\ref{fig:comp_tools_ti}A right), or may be embedded in a dimensionality reduction of the cells to better demonstrate cellular heterogeneity along the trajectory (Figure~\ref{fig:comp_tools_ti}B right). Similar to clustering, by colouring the cells according to the expression of genes known to be involved in the dynamic process of interest, the milestones in the trajectory can be annotated (Figure~\ref{fig:comp_tools_ti}B).

\begin{figure}[htb!]
	\centering
	\includegraphics[width=.9\linewidth]{fig/comptools2/comptool_3_trajectoryinference.pdf} 
	\caption{
		\textbf{Trajectory inference for single-cell omics data.}
		\textbf{A:} During a dynamic process cells pass through several transitional states, characterized by different waves of transcriptional, morphological, epigenomic and/or surface marker changes \cite{enver_stemcellstates_2009}. TI methods provide an unbiased approach to identifying and correctly ordering different transitional stages. 
		\textbf{B:} By overlaying gene expression levels on a dimensionality reduction, the milestones can be annotated to allow better interpretation of the cellular heterogeneity.
	}
	\label{fig:comp_tools_ti}
\end{figure}

Groups of TI methods use similar algorithms to infer a trajectory. By breaking down each method into its set of core algorithms, we can create a map of TI methodology \cite{cannoodt_computationalmethodstrajectory_2016} (Figure~\ref{fig:ti_metro}A), which is divided into two major classes.
In the first step, dimensionality reduction techniques such as manifold learning, clustering, or graph-based methods are used to convert the dataset to a more simplified representation. This representation of the data then allows the trajectory itself to be more easily modelled in a second step. In this second step, the trajectory is modelled within the data using graph-based or curve-based approaches, after which the cells themselves can be ordered using a variety of methods.

A common way to classify TI methods is by the types of trajectories they can infer \cite{saelens_comparisonsinglecelltrajectory_2019} (Figure~\ref{fig:ti_metro}B). About half of TI methods specialise in inferring linear or cyclic trajectories (i.e. they order the cells). Others model the trajectory as a rooted tree, allowing for one or more bifurcations to occur. Only a few methods are able to infer more generalised trajectories containing disconnected subgraphs or cycles.

\begin{figure}[htb!]
	\centering
	\includegraphics[width=.9\linewidth]{fig/ti_metro} 
	\caption{
		\textbf{TI methods use several common building blocks and can be organized in a unifying modular framework.} 
		\textbf{A:} Most TI methods consist of two major steps, dimensionality reduction and trajectory modelling. TI methods   require some form of dimensionality reduction in order to summarise cell heterogeneity in a lower dimensional space. Subsequently, a trajectory modelling step then operates in this reduced space, aiming to identify cell states, constructing a trajectory through the different states, and projecting the cells back on to the trajectory. 
		\textbf{B:} TI methods can be classified according to the trajectory topologies they can infer.
	}
	\label{fig:ti_metro}
\end{figure}


\subsection{Differential expression}
Given that cells are split up two or more groups -- either through clustering or prior knowledge -- differential expression (DE) methods attempt to identify a group of genes that are expressed significantly higher or lower in one group in comparison to the others. Main applications of DE methods are the development of population signatures or simply the visualisation of the main difference between several groups in a compact manner (Figure~\ref{fig:comp_tools_de}A). 
 
Trajectory differential expression (TDE) is an extension of DE where instead genes are prioritised according to whether their gene expression changes smoothly but significantly along a parts of a trajectory (Figure~\ref{fig:comp_tools_de}). 

\begin{figure}[htb!]
	\centering
	\includegraphics[width=.6\linewidth]{fig/comptools2/comptool_4_differentialexpression.pdf} 
	\caption{
		\textbf{Differential expression for single-cell omics data.}
		\textbf{A:} Differential expression methods prioritises genes that are expressed significantly higher or lower in particular given groups.
		\textbf{B:} Trajectory differential expression prioritises genes that change smoothly but significantly along particular transitions in a trajectory.
	}
	\label{fig:comp_tools_de}
\end{figure}

\subsection{Network inference}
One of the central cellular processes underlying development is transcriptional regulation. 	
Modelling gene regulation is essential to better understand what drives cells to develop in the way that they do and to identify what goes wrong in the case of disease.

Network inference (NI) methods predict for every gene (or a subset thereof) by which transcription factors they are regulated (Figure~\ref{fig:comp_tools_ni}). The output of a network inference is a graph in which nodes represent genes and edges denote a regulatory interaction between a regulator and a target gene. Interactions can have two properties: its regulatory strength (a positive real value) and its effect (promoting or repressing).

Before single-cell omics, these methods rely on multiple experiments, amongst which perturbation and time-series experiments, to predict the effect each transcription factor has on the up- or downregulation of a gene. One of the main advantages of single-cell omics is the heterogeneity between cells caused by naturally occurring biological randomness \cite{padovan-merhar_usingvariabilitygene_2013} can be exploited to infer regulatory interactions between TFs and their target genes at much lower costs. 

\begin{figure}[htb!]
	\centering
	\includegraphics[width=.6\linewidth]{fig/comptools2/comptool_5_networkinference.pdf}
	\caption{
		\textbf{Network inference for single-cell omics data.}
	}
	\label{fig:comp_tools_ni}
\end{figure}

\section{Benchmarking computational tools}

Recent technological advancements in profiling single cells are having significant repercussions in many fields of biology. Profiling thousands of individual cells in a genome-wide manner provides opportunities to study cell heterogeneity and dynamics, for example inferring mechanisms for cellular development or intercellular communication. 
Hundreds of new software tools were developed \cite{zappia_exploringsinglecellrnaseq_2018} to perform these new types of analyses, or to fit existing analytical tools to deal with new data characteristics (e.g. differential expression, dimensionality reduction, normalisation). 

One major shortcoming during the advent of single-cell omics was that the majority of newly developed computational tools were not quantitatively and comparatively evaluated. Rather, they relied on anecdotal evidence to demonstrate its usefulness. 

As a demonstration, we perform a brief review of 75 articles introducing new TI methods, but the findings presented are generalisable to single-cell omics in general. Out of 75 articles, only about 37\% of articles contain a self-assessment (Figure \ref{fig:benchmarks_over_time}). Peer-reviewed articles fared even worse, self-assessing in only 35\% of cases, whereas articles first published as a pre-print self-assess in 44\% of cases.

While self-assessments are universally biased in favour of the authors \cite{norel_selfassessmenttrapcan_2011} (intentionally or not), it is dangerous and unusual to publish a computational tool without quantitatively demonstrating its performance compared to state-of-the-art methods. Uncontrolled development of software tools without comprehensive benchmarking poses serious problems. For one, it slows down scientific progress. Every end-user needs to make a large commitment researching the domain in order to make an informed decision of which tool to use, or risk a higher incidence of false positive discoveries (either way, valuable resources are being wasted). In addition, it also negatively impacts the credibility of the field, thus discouraging potential users or researchers from entering.

This issue is likely not due to the tool developer's malevolence, but instead due to the absence of benchmarking methodology for this application, which can include standardised problem definitions, readily available benchmarking datasets, and suitable metrics.
Each of these topics is discussed in more detail below.

\begin{figure}[htb!]
	\centering
	\includegraphics[width=.75\linewidth]{fig/selfassessment/self_assessment.pdf}
	\caption{
		\textbf{Less than half of all TI articles perform quantitative self-assessment.}
		\textbf{A:} Since 2016, the number of TI articles has been increasing rapidly. Note that TI methods with both a pre-print and a peer-reviewed article only count once in the overall tally.
		\textbf{B:} Less than 50\% of articles feature a self-assessment. Peer-reviewed articles self-assess only in 34\% of cases.
	}
	\label{fig:benchmarks_over_time}
\end{figure}

\subsection{Problem definition} 
One main reason why benchmarking TI methods is difficult is due to there being slight variations of the problem a method is attempting to solve. For example, a TI method might infer linear or cyclic trajectories, or predict the probability of a cell ending up in one of several end states.

These differences reflect themselves in the input and output interfaces of each method, making it harder to directly compare methods directly. By constructing a generalised version that encompasses the different sub-problems and wrapping each method accordingly allows to fix the interface to make methods directly comparable.

Additionally, differences in problem definitions might complicate knowledge discovery to find similar methods, as certain articles might only show up with specific search terms. For the discoverability of a new TI method, it is therefore essential to use include generalised terminology, or at least list it as one of the keywords.

\subsection{Datasets} 
During the infancy of the relatively domain of single-cell omics, large well-annotated datasets that can be used to benchmark novel computational tools are scarce and expensive to generate.  When adequate benchmarking datasets are lowly abundant, synthetic data is often used to evaluate computational methods, either standalone or to complement real data. 

Benefits of synthetic data are that they offer more control over the data characteristics and that they can be generated in large quantities. This allows evaluating the performance of a method in function of a changing parameter (e.g.~dataset size or noise levels), which provides information on how well the method will work on real datasets.

A common counterargument of synthetic data is that they generate unrealistic datasets and thus provide no additional value in evaluating a method. In contrast, we argue that a good set of synthetic datasets should allow benchmarkers to verify that a method should \textit{at least} work well on the synthetic datasets, but good performance on synthetic datasets does not guarantee good performance on real datasets.

\subsection{Metrics}
To evaluate a computational tools, a quantitative metric is needed to compare  the often complex multi-layered data structures of the ground-truth dataset to predictions thereof, or to compare the data structures of multiple predictions. When adequate metrics are lacking, it is advisable to re-purpose metrics from other domains and adapt them, if necessary.

A second important criterion is to evaluate the robustness of predictions by comparing multiple executions of the same method. Computing the robustness does not replace the necessity of a relevant metric that captures whether a predicted trajectory resembles the ground truth.

\section{Research context and objectives} \label{sec:research_objectives}
Technological breakthroughs in single-cell omics profiling have resulted in a wealth of information on the biomolecular contents of individual cells. In this work, we aim to speed up scientific discovery by developing and benchmarking computational tools for generating high-quality hypotheses in a high-throughput and data-driven manner.

The objectives of this work can be reduced to three main questions. How do cells change over time? What drives cells to change? How good are these predictions?

We tackle these three questions using three respective approaches, namely trajectory inference, network inference, and benchmarking (Figure~\ref{fig:overview_thesis}). Each of the chapters in this work contributes to answering a part of one or more of these questions.

\begin{figure}[htb!]
	\centering
	\includegraphics[width=.75\linewidth]{fig/overview_cropped.pdf}
	\caption{Overview}
	\label{fig:overview_thesis}
\end{figure}

\paragraph{Trajectory inference} We develop a simulator of developing single cells (Chapter~\ref{chap:dyngen}). We use synthetic data to complement real data in benchmarking TI methods in terms of accuracy, stability, scalability and usability (Chapter~\ref{chap:dynbenchmark}). Based on these results, we provide guidelines to end-users on how to perform trajectory inference analysis. We introduce a novel TI method specialised in inferring linear trajectories which outperforms state-of-the-art existing methods (Chapter~\ref{chap:scorpius}). Finally, we provide a full-stack toolkit for performing inferring, visualising and interpreting trajectories from more than 50 different TI methods (Chapter~\ref{chap:dyno}).

\paragraph{Network inference} We explore a novel algorithm for inferring gene regulatory interactions at a single-cell level (Chapter~\ref{chap:bred}). We demonstrate our NI methodology by inferring regulatory interactions for 14'963 profiles of cancer patients. We provide a tool for analysing the topological properties of large, evolving networks and use this to iteratively optimise GRN predictions (Chapter~\ref{chap:incgraph}).

\paragraph{Benchmarking} Using our synthetic single-cell generator, we develop benchmarking strategies for assessing the performance of novel types of single-cell omics tools which are currently in a conceptual or prototypical state (Chapter~\ref{chap:dyngen}). We summarise our experience in benchmarking computational methods by providing a list of essential guidelines in how to benchmark computational tools (Chapter~\ref{chap:guidelines}).


%\begin{itemize}
%	\item We \textbf{develop benchmarking strategies} for assessing the performance of computational tools constrained by low availability of novel types of real single-cell data (Chapter~\ref{chap:dyngen}). \textit{In silico} simulations of individual cells are used to help kick-start emerging domains much more safely and allow anticipation of future technological developments by already developing computational tools.
%	\item We apply this strategy to \textbf{perform a comparison of TI methods} (Chapter~\ref{chap:dynbenchmark}). Trajectory inference is one of the largest categories of all the novel single-cell omics tools, yet a comprehensive and quantitative study of the advantages and disadvantages of the numerous tools was hitherto lacking. We provide a set of guidelines for end-users wishing to infer trajectories. Our pipeline, datasets, metrics, and containerised wrappers of TI methods are made publicly available for developers to use.
%	\item We introduce a TI method specialised in \textbf{inferring linear trajectories} (Chapter~\ref{chap:scorpius}). Despite linear TI being the most simple but commonly used form of trajectory inference, the benchmark demonstrated that most TI methods are not capable of producing accurate models of linear datasets.
%	\item We develop \textbf{a toolkit to infer, visualise and interpret single-cell trajectories} using more than 50 different TI methods (Chapter~\ref{chap:dyno}). This toolkit provides downstream analysis such as: visualising a trajectory in a low-dimensional space or a heatmap, detecting genes differentially expressed at different stages of the trajectory, comparing multiple trajectories in a common dimensionality reduction, and manipulating the trajectory (e.g. adding directionality or adding annotation).
%	\item We explore a novel algorithm for \textbf{inferring gene regulatory interactions at a single-cell level} (Chapter~\ref{chap:bred}). We demonstrate our NI methodology by inferring regulatory interactions for 14'963 profiles of cancer patients.
%	\item We provide a tool for \textbf{analysing the topological properties of large, evolving networks} and use this to iteratively optimise GRN predictions (Chapter~\ref{chap:incgraph}).
%	\item Finally, we \textbf{summarise our experience in benchmarking computational methods} by providing a list of essential guidelines in benchmarking computational tools (Chapter~\ref{chap:guidelines}).
%\end{itemize}

\newpage 
\section{Hippocratic oath for method developers}
Before setting out on this perilous journey, I write a Hippocratic oath 
which I believe all developers of computational tools should swear by 
before haphazardly creating new tools. 

\begin{figure}[htb!]
	\centering
	\begin{tcolorbox}
		\begin{itemize}
			\item In developing a new computational tool, I swear to fulfil, to the best of my ability, the following items:
			\item I will write software that works reliably but fails gracefully when it does not.
			\item I will assert that my method produces accurate and reproducible results.
			\item I will validate the performance of my tool with previously unseen data from third-party sources.
			\item I will use suitable quantitative performance metrics. If possible, I use multiple metrics to avoid overfitting.
			\item I will compare the performance to relevant methods.
			\item I will report positive achievements of my method, but also be critical of it, and discuss areas in which it performs suboptimally.
			\item I will write unit tests to ensure that each component in my tool works as intended. If the tool produces unexpected errors when tested on various edge cases, my tool will be perceived as dysfunctional by others.
			\item I will follow reproducible research best practices, by making code and data publicly available.
		\end{itemize}
	\end{tcolorbox}
	\caption{
		\textbf{A hippocratic oath for computational method developers.} Inspired by Laplante\cite{laplante_firstnoharm_2004} and lists of guidelines for benchmarking\cite{norel_selfassessmenttrapcan_2011,weber_essentialguidelinescomputational_2019}
	}
	\label{fig:hippocratic_oath}
\end{figure}



\clearpage
\section{References}
\printbibliography[heading=none]